Citryll
PrivateLast Round
Series B
Dec 9, 2024
Total Funding Raised
$110.7M
Momentum Score
75 /100
Company Overview
Citryll is a biotechnology company that develops pharmaceutical drugs designed to treat autoimmune and other human diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Citryll Comps
Public and private peers based on sector, stage, and business model.
Citryll Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Dec 9, 2024 | ||||
| Grant | Oct 3, 2024 | ||||
| Grant | Jul 2, 2020 | ||||
| Series A | Jul 2, 2020 |
Key People
Founding team and executive leadership
Citryll Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Brabantse Ontwikkelings Maatschappij | Series B |
| BOM Brabant Ventures | Series A |
| Novartis Venture Fund | Series B |
| Pureos Bioventures | Series B |
| BioGeneration Ventures | Series B, Series A |
| Seventure Partners | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 15, 2026
Developing the first ET-targeting therapy for immune-mediated inflammatory diseases.
- Jun 30, 2025
CIT-013 is a first-in-class antibody for immune-mediated inflammatory diseases.
Citryll Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Citryll's valuation, stock price, and market status.
